Trial · NCT07881497
A Retrospective Chart Abstraction to Investigate the Prevalence of Chronic Sialorrhea, and the Real-world Use of incobotulinumtoxinA Injections in Male and Female Participants Aged 18 Years and Older With Chronic Sialorrhea
NCT07881497, Completed, Medstar Health Research Institute
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Retrospective Chart Abstraction to Investigate the Prevalence of Chronic Sialorrhea, and the Real-world Use of incobotulinumtoxinA Injections in Male and Female Participants Aged 18 Years and Older With Chronic Sialorrhea. Trials, record NCT07881497. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07881497
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
A Retrospective Chart Abstraction to Investigate the Prevalence of Chronic Sialorrhea, and the Real-world Use of incobotulinumtoxinA Injections in Male and Female Participants Aged 18 Years and Older With Chronic Sialorrhea
- NCT number
- NCT07881497
- Status
- Completed
- Enrollment
- 206 participants, actual
- Lead sponsor
- Medstar Health Research Institute
- Conditions
- Sialorrhea
- First posted
- 2026-10-19
- Last updated
- 2026-10-19
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Chart abstraction measured sialorrhea and its treatment in different neurological conditions | 6 months | Chart abstraction measured sialorrhea and its treatment in different neurological conditions 11/1/2024 to 4/30/2025 |
| Secondary | Correlation between the onset of sialorrhea and disease state | 6 months | Correlation between the onset of sialorrhea and disease state from 11/01/2014-04/01/2025 |
| Secondary | Dosage of incobotulinumtoxinA used per gland and overall, in the treatment of chronic sialorrhea. | 6 months | Describe dosage of incobotulinumtoxinA used per gland and overall, in the treatment of chronic sialorrhea from 11/01/2024 to 04/01/2025 |
| Secondary | Dose development of incobotulinumtoxinA over time | 6 months | Describe dose development of incobotulinumtoxinA over time for Siallorhea |
| Secondary | Treatment pathway of sialorrhea | 6 months | Describe treatment pathway of sialorrhea |
| Secondary | Patient population receiving incobotulinumtoxinA for sialorrhea treatment | 6 months | Describe patient population receiving incobotulinumtoxinA for sialorrhea treatment |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07881497
GET https://conductscience.org/api/trials/v1/NCT07881497/registered